ArticleFrontiers in pediatrics2023

Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations.

Si-Jia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.